LAG-3 acts synergistically with PD-1 and/or CTLA-4 to limit T-cell expansion, and LAG-3+ T-cells inhabit cHL ME [31,32,33,34]. This evidence concerns the gene LAG3 and classic Hodgkin lymphoma.